AT517607T - A method for producing particles for use in a pharmaceutical composition - Google Patents

A method for producing particles for use in a pharmaceutical composition

Info

Publication number
AT517607T
AT517607T AT01998328T AT01998328T AT517607T AT 517607 T AT517607 T AT 517607T AT 01998328 T AT01998328 T AT 01998328T AT 01998328 T AT01998328 T AT 01998328T AT 517607 T AT517607 T AT 517607T
Authority
AT
Austria
Prior art keywords
use
method
pharmaceutical composition
producing particles
particles
Prior art date
Application number
AT01998328T
Other languages
German (de)
Inventor
John Staniforth
Matthew Green
David Morton
Original Assignee
Vectura Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to GB0029261A priority Critical patent/GB0029261D0/en
Priority to GB0030946A priority patent/GB0030946D0/en
Priority to PCT/GB2001/001606 priority patent/WO2001076575A2/en
Priority to GB0124010A priority patent/GB0124010D0/en
Application filed by Vectura Ltd filed Critical Vectura Ltd
Priority to PCT/GB2001/005315 priority patent/WO2002043701A2/en
Publication of AT517607T publication Critical patent/AT517607T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31891809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT517607(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/5115Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/501Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5015Organic compounds, e.g. fats, sugars
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089Processes
AT01998328T 2000-04-07 2001-11-30 A method for producing particles for use in a pharmaceutical composition AT517607T (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0029261A GB0029261D0 (en) 2000-11-30 2000-11-30 Method of making particles for use in a pharmaceutical composition
GB0030946A GB0030946D0 (en) 2000-12-19 2000-12-19 Method of making particles for use in a pharmaceutical composition
PCT/GB2001/001606 WO2001076575A2 (en) 2000-04-07 2001-04-09 The treatment of respiratory diseases
GB0124010A GB0124010D0 (en) 2001-10-05 2001-10-05 Pharmaceutical compositions for inhalation
PCT/GB2001/005315 WO2002043701A2 (en) 2000-11-30 2001-11-30 Method of making particles for use in a pharmaceutical composition

Publications (1)

Publication Number Publication Date
AT517607T true AT517607T (en) 2011-08-15

Family

ID=31891809

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01998328T AT517607T (en) 2000-04-07 2001-11-30 A method for producing particles for use in a pharmaceutical composition
AT01998329T AT382335T (en) 2000-04-07 2001-11-30 A process for the preparation of microparticles for use in pharmaceutical compositions for inhalation

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT01998329T AT382335T (en) 2000-04-07 2001-11-30 A process for the preparation of microparticles for use in pharmaceutical compositions for inhalation

Country Status (9)

Country Link
US (11) US7736670B2 (en)
EP (6) EP2298285A3 (en)
JP (1) JP5192447B2 (en)
AT (2) AT517607T (en)
CY (2) CY1112338T1 (en)
DK (3) DK2283817T3 (en)
ES (3) ES2474199T3 (en)
HK (2) HK1058145A1 (en)
PT (4) PT2283817T (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
EP2298285A3 (en) * 2000-11-30 2011-07-27 Vectura Limited Method of making particles for use in a pharmaceutical composition
DK1913939T3 (en) 2000-06-27 2017-09-18 Vectura Ltd Formulations for use in inhalers
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
AT446085T (en) * 2000-11-30 2009-11-15 Vectura Ltd Particles for use in a pharmaceutical composition
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US20120321717A1 (en) * 2003-04-14 2012-12-20 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
US20060147389A1 (en) * 2004-04-14 2006-07-06 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20050056958A1 (en) * 2003-09-16 2005-03-17 Eastman Kodak Company Forming homogeneous mixtures of organic materials for physical vapor deposition using dry mixing
GB0409703D0 (en) * 2004-04-30 2004-06-02 Vectura Ltd Pharmaceutical compositions
GB0418791D0 (en) 2004-08-23 2004-09-22 Glaxo Group Ltd Novel process
GB0425758D0 (en) 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
EP1849830B1 (en) * 2005-01-28 2012-02-29 Takeda Pharmaceutical Company Limited Finely divided composition containing poorly water soluble substance
US7951419B2 (en) * 2005-07-21 2011-05-31 Multisorb Technologies, Inc. Dry-coated oxygen-scavenging particles and methods of making them
CA2631492A1 (en) * 2005-12-15 2007-06-21 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US8969402B2 (en) 2006-11-15 2015-03-03 Steven A. Rich Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
US7883039B2 (en) * 2007-02-27 2011-02-08 Collette Nv Continuous granulating and drying apparatus including measurement units
EP2234595B1 (en) * 2007-12-13 2012-11-28 Novartis AG Process for reducing the tendency of a glycopyyronium salt to aggegate during storage.
EP2229148B1 (en) * 2007-12-13 2014-03-05 Novartis AG Process for preparing a particulate and crystalline drug substance
WO2010014846A1 (en) * 2008-07-30 2010-02-04 T & T Enterprises Inc. Antioxidant additive
US20120064126A1 (en) 2009-03-26 2012-03-15 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
BRPI1014275A2 (en) 2009-04-24 2016-10-18 Iceutica Pty Ltd new indomethacin formulation
KR20160148041A (en) * 2009-04-24 2016-12-23 아이슈티카 피티와이 리미티드 Production of encapsulated nanoparticles at commercial scale
NZ595973A (en) * 2009-04-24 2014-02-28 Iceutica Pty Ltd Production of encapsulated nanoparticles at high volume fractions
PL2435025T3 (en) 2009-05-29 2017-08-31 Pearl Therapeutics, Inc. Respiratory delivery of active agents
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2011224397A1 (en) * 2010-03-09 2012-09-06 Stc.Unm Apparatuses and methods for microparticle dry coating of surfaces
DK2621488T3 (en) * 2010-09-29 2019-03-04 Pulmatrix Operating Company Inc Cationic dry powder
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CN105640925B (en) * 2010-08-30 2019-08-16 普马特里克斯营业公司 Dried powder formula and method for treating pulmonary disease
US9642798B2 (en) 2010-09-29 2017-05-09 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
SG10201703243QA (en) * 2012-02-28 2017-06-29 Iceutica Holdings Inc Inhalable pharmaceutical compositions
MX2012003548A (en) * 2012-03-23 2013-09-23 Copamex S A De C V Super-hydrophobic composition, preparation of same and super-hydrophobic paper.
KR20140147891A (en) 2012-04-13 2014-12-30 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Aggregate particles
WO2014165303A1 (en) 2013-04-01 2014-10-09 Pulmatrix, Inc. Tiotropium dry powders
EA029125B1 (en) * 2013-07-11 2018-02-28 Кьези Фармасьютичи С.П.А. Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
CN104955029A (en) * 2014-03-24 2015-09-30 中兴通讯股份有限公司 Address book protection method, address book protection device and communication system
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
JP2018519289A (en) * 2015-06-15 2018-07-19 キューエーエーエム ファーマシューティカルズ,エルエルシー Glycopyrronium fatty acid salt and method for making glycopyrronium fatty acid salt

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1240092A (en) 1970-01-08 1971-07-21 Dynamic Tools Ltd A swivel connector
GB1381872A (en) 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
US5192528A (en) 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
IT1204826B (en) 1986-03-04 1989-03-10 Chiesi Farma Spa Pharmaceutical compositions for inhalation
NZ221411A (en) * 1986-08-11 1989-10-27 Innovata Biomed Ltd Pharmaceutical compositions containing microcapsules and a surfactant
US5320906A (en) * 1986-12-15 1994-06-14 Vestar, Inc. Delivery vehicles with amphiphile-associated active ingredient
JP2668880B2 (en) 1987-06-23 1997-10-27 日本油脂株式会社 Manufacturing method for coating amino acids
US5190764A (en) 1988-03-03 1993-03-02 Hokko Chemical Industry Co., Ltd. Agent for imparting a sustained release property to a pesticide, a pesticide having a sustained release property and a process for the production thereof
US5223244A (en) 1988-06-20 1993-06-29 Shiseido Company, Ltd. Aerosol composition
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
DE69027319T2 (en) * 1989-04-28 1996-11-21 Riker Laboratories Inc Inhalation device for dry powder
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5376386A (en) 1990-01-24 1994-12-27 British Technology Group Limited Aerosol carriers
GB9024365D0 (en) 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5413804A (en) 1991-04-23 1995-05-09 Cacique, Inc. Process for making whey-derived fat substitute product and products thereof
DE4140689B4 (en) 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalation powders and methods for their preparation
JP2735979B2 (en) * 1992-04-23 1998-04-02 花王株式会社 Resin powder and cosmetics
DE69332240T2 (en) * 1992-06-12 2003-04-10 Teijin Ltd Ultra-fine powder for inhalation, and whose production
GB2269992A (en) 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
JPH0696517A (en) 1992-09-11 1994-04-08 Matsushita Electric Ind Co Ltd Magnetic disk apparatus
SE9203743D0 (en) * 1992-12-11 1992-12-11 Astra Ab Efficient use
US5672581A (en) 1993-01-29 1997-09-30 Aradigm Corporation Method of administration of insulin
US5506203C1 (en) 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
DE4323636A1 (en) * 1993-07-15 1995-01-19 Hoechst Ag Drug preparations of coated, heavy water-soluble drugs for inhalation dosage forms and methods for their preparation
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5441753A (en) * 1994-01-28 1995-08-15 Fmc Corporation Coprocessed particulate bulking and formulating AIDS: their composition, production, and use
EP1462096B1 (en) * 1994-03-07 2008-12-10 Nektar Therapeutics Methods and compositions for pulmonary delivery of insulin
US5711934A (en) * 1994-04-11 1998-01-27 Abbott Laboratories Process for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants
US5647347A (en) 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US6103271A (en) * 1994-12-02 2000-08-15 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microencapsulation and electrostatic processing method
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
BR9510510A (en) * 1994-12-22 1998-07-07 Astra Ab Pharmaceutical aerosol formulation use thereof and processes for the manufacture thereof for treating a patient in need of therapy
SA429B1 (en) 1994-12-22 2005-10-04 استرا أكتيبولاج Powders for inhalation
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
US5635160A (en) * 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
SE9502799D0 (en) 1995-08-10 1995-08-10 Astra Ab Device in inhalers
US5997846A (en) 1997-11-17 1999-12-07 Albert Einstein College Of Medicine Of Yeshiva University Method for detecting arthropods
US6178414B1 (en) 1997-12-16 2001-01-23 Nortel Networks Limited Method and apparatus for updating and searching an ordered list of values stored within a memory resource
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
US20030118514A1 (en) * 1998-03-26 2003-06-26 Glaxo Wellcome Inc. Compositions for inhalation
US5945123A (en) 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
AU755066B2 (en) 1998-04-18 2002-12-05 Glaxo Group Limited Pharmaceutical aerosol formulation
GT199900148A (en) * 1998-09-10 2001-02-28 Denaturants to sympathomimetic amines salts.
US7521068B2 (en) * 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
DE59914603D1 (en) * 1998-11-13 2008-02-14 Jagotec Ag Multidose dry powder reservoir
US20070212422A1 (en) * 1999-11-10 2007-09-13 Manfred Keller Dry powder for inhalation
US20010020242A1 (en) * 1998-11-16 2001-09-06 Amit Gupta Method and apparatus for processing client information
US6984404B1 (en) 1998-11-18 2006-01-10 University Of Florida Research Foundation, Inc. Methods for preparing coated drug particles and pharmaceutical formulations thereof
HU0104687A3 (en) * 1998-11-18 2006-07-28 Univ Florida Methods for preparing coated drug particles and pharmaceutical formulations thereof
GB9826783D0 (en) 1998-12-04 1999-01-27 Scherer Ltd R P Inhalation powders
GB9827145D0 (en) * 1998-12-09 1999-02-03 Co Ordinated Drug Dev Improvements in or relating to powders
US6542490B1 (en) * 1999-01-29 2003-04-01 Nortel Networks Limited Data link control proctocol for 3G wireless system
DK1158958T3 (en) 1999-03-05 2007-10-08 Chiesi Farma Spa Improved powder formulation for inhalation
IT1309592B1 (en) 1999-03-05 2002-01-24 Chiesi Farma Spa Particles vehicle modified to be used in the pharmaceutical preparation in the form of polymers diformulazioni by inhalation and
US7090831B1 (en) * 1999-04-14 2006-08-15 Smithkline Beecham Corporation Pharmaceutical aerosol formulation
US6406745B1 (en) 1999-06-07 2002-06-18 Nanosphere, Inc. Methods for coating particles and particles produced thereby
ITMI991582A1 (en) 1999-07-16 2001-01-16 Chiesi Farma Spa Powder consisting of particles having a perfectly smooth surface to be used as vehicles for the preparation of mixtures inhales
US6197369B1 (en) 1999-09-30 2001-03-06 New Jersey Institute Of Technology Method of particle coating
GB0008660D0 (en) 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
EP2298285A3 (en) 2000-11-30 2011-07-27 Vectura Limited Method of making particles for use in a pharmaceutical composition
PE12272001A1 (en) 2000-04-17 2002-01-07 Chiesi Farma Spa Pharmaceutical formulations for DPIs in the form of hard agglomerates
GB0009469D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
GB0009468D0 (en) 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
DK1913939T3 (en) 2000-06-27 2017-09-18 Vectura Ltd Formulations for use in inhalers
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US6404772B1 (en) 2000-07-27 2002-06-11 Symbol Technologies, Inc. Voice and data wireless communications network and method
AU2002211311B2 (en) 2000-10-09 2006-08-31 3M Innovative Properties Company Medicinal aerosol formulations
ES2227268T3 (en) 2000-10-12 2005-04-01 BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG New inhalable powders containing tiotropium.
AT446085T (en) 2000-11-30 2009-11-15 Vectura Ltd Particles for use in a pharmaceutical composition
US20060147389A1 (en) 2004-04-14 2006-07-06 Vectura Ltd. Devices and pharmaceutical compositions for enhancing dosing efficiency
US20060292081A1 (en) 2003-09-15 2006-12-28 Vectura Limited Methods for preparing pharmaceutical compositions
GB0321607D0 (en) * 2003-09-15 2003-10-15 Vectura Ltd Manufacture of pharmaceutical compositions
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
GB0426301D0 (en) * 2004-11-30 2004-12-29 Vectura Ltd Pharmaceutical formulations
KR101895759B1 (en) * 2009-12-14 2018-09-05 키에시 파르마슈티시 엣스. 피. 에이. Antibiotic microparticles for inhalation

Also Published As

Publication number Publication date
ES2587135T3 (en) 2016-10-20
DK1337240T4 (en) 2015-01-05
US20040047810A1 (en) 2004-03-11
US9931304B2 (en) 2018-04-03
DK2283817T3 (en) 2016-09-05
EP3269360A1 (en) 2018-01-17
US20130344156A1 (en) 2013-12-26
US20150086640A1 (en) 2015-03-26
DK1337240T3 (en) 2011-11-21
HK1058145A1 (en) 2011-11-25
ES2708961T3 (en) 2019-04-12
AT382335T (en) 2008-01-15
US20040037785A1 (en) 2004-02-26
EP1920763B1 (en) 2014-04-02
US20150079185A1 (en) 2015-03-19
ES2474199T3 (en) 2014-07-08
PT1920763E (en) 2014-06-25
PT1337240E (en) 2011-11-02
US20160243046A1 (en) 2016-08-25
EP2283818A1 (en) 2011-02-16
US20120027863A1 (en) 2012-02-02
US8956661B2 (en) 2015-02-17
JP5192447B2 (en) 2013-05-08
DK1920763T3 (en) 2014-07-07
US8932635B2 (en) 2015-01-13
EP2283818B1 (en) 2017-08-02
HK1154347A1 (en) 2017-04-28
PT2283818T (en) 2017-10-09
US9962338B2 (en) 2018-05-08
EP2283817B1 (en) 2016-05-18
EP2298285A3 (en) 2011-07-27
US8435567B2 (en) 2013-05-07
CY1112338T1 (en) 2015-12-09
EP2298279A2 (en) 2011-03-23
EP2298285A2 (en) 2011-03-23
CY1115304T1 (en) 2017-01-04
EP2298279A3 (en) 2011-08-03
US8303991B2 (en) 2012-11-06
US20100209358A1 (en) 2010-08-19
EP1920763A1 (en) 2008-05-14
US8048451B2 (en) 2011-11-01
US20170266122A1 (en) 2017-09-21
US20170172947A1 (en) 2017-06-22
EP2298279B1 (en) 2018-11-14
US20130017267A1 (en) 2013-01-17
US7736670B2 (en) 2010-06-15
EP2283817A1 (en) 2011-02-16
PT2283817T (en) 2016-08-22
JP2009242408A (en) 2009-10-22
US10188612B2 (en) 2019-01-29

Similar Documents

Publication Publication Date Title
DE69935891D1 (en) A method for producing a Motorhubventils
DE60106526D1 (en) New N-acetylglutamate-mutant and a process for producing L-arginine
AT304455T (en) A method and apparatus for the production of booklets
DE602004003389D1 (en) A process for the preparation of 4'-azidonukleosidderivaten
AT518812T (en) A process for the preparation of reactive magnesiumoxidzementen
DE69918723D1 (en) A process for preparing fluoropolymers
AT549381T (en) A method for preparing modified pigments
DE69933689D1 (en) A process for preparing oral calcium compositions
DE69841475D1 (en) A method for producing a MOSFET
AT266365T (en) Method for computer-controlled production of dentures
DE69817881D1 (en) A process for producing a laminate
DE60043439D1 (en) A process for the manufacture of waveguides in ceramic multilayer structures
DE60036632D1 (en) A process for preparing a sorbentzusammensetzung and their use in desulfurization
DE60108184D1 (en) A process for preparing Fettsäureestern
DE60132937D1 (en) A process for the preparation of benzimidazol-2-yl -Chinolinonderivaten
DE60140142D1 (en) A process for producing a bone cement
DE60001944T2 (en) A process for the preparation of particles
DE60115271D1 (en) A process for preparing seidenfibroinvliesstoffen
DE69942636D1 (en) A process for producing glycoprotein with a human glycosylierungsbild
DE60022610D1 (en) Process for coding animation in an image file
AT271380T (en) A process for the manufacture of polymer-micelle composition wirkstofbeladenen
AT378039T (en) Production method of particles for use in a pharmaceutical composition
DE60033061D1 (en) A process for preparing siloxancopolycarbonaten
DE60030949D1 (en) A method for producing a card
DE50115197D1 (en) A process for the manufacture of brushware and Brushware

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1337240

Country of ref document: EP